Article info

Original research
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling

Authors

  • Ihor Arkhypov Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Centre, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDFKZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Feyza Gül Özbay Kurt Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Centre, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDFKZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Rebekka Bitsch Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Centre, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDFKZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Daniel Novak Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Centre, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDFKZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Vera Petrova Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Centre, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDFKZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Samantha Lasser Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Centre, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDFKZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Thomas Hielscher Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Christopher Groth Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Centre, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDFKZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Alisa Lepper Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Centre, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDFKZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Xiaoying Hu Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Centre, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDFKZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Wei Li Department of Dermatology and the USC-Norris Comprehensive Cancer Centre, University of Southern California Keck Medical Center, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Jochen Utikal Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Centre, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDFKZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Peter Altevogt Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Centre, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDFKZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Viktor Umansky Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Centre, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDFKZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, GermanyMannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Viktor Umansky; V.Umansky{at}dkfz-heidelberg.de
View Full Text

Citation

Arkhypov I, Özbay Kurt FG, Bitsch R, et al
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling

Publication history

  • Accepted September 1, 2022
  • First published September 16, 2022.
Online issue publication 
September 16, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.